IL122302A - Use of 1,4-dihydropyridine derivatives in the preparation of a medicament for the prevention and therapy of atherosclerotic degradation of arterial walls and pharmaceutical compositions containing such derivatives - Google Patents
Use of 1,4-dihydropyridine derivatives in the preparation of a medicament for the prevention and therapy of atherosclerotic degradation of arterial walls and pharmaceutical compositions containing such derivativesInfo
- Publication number
- IL122302A IL122302A IL12230296A IL12230296A IL122302A IL 122302 A IL122302 A IL 122302A IL 12230296 A IL12230296 A IL 12230296A IL 12230296 A IL12230296 A IL 12230296A IL 122302 A IL122302 A IL 122302A
- Authority
- IL
- Israel
- Prior art keywords
- derivatives
- medicament
- therapy
- prevention
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI951513A IT1275532B (it) | 1995-07-14 | 1995-07-14 | Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa |
| PCT/EP1996/002872 WO1997003669A1 (en) | 1995-07-14 | 1996-06-28 | Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL122302A0 IL122302A0 (en) | 1998-04-05 |
| IL122302A true IL122302A (en) | 2000-08-13 |
Family
ID=11371972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12230296A IL122302A (en) | 1995-07-14 | 1996-06-28 | Use of 1,4-dihydropyridine derivatives in the preparation of a medicament for the prevention and therapy of atherosclerotic degradation of arterial walls and pharmaceutical compositions containing such derivatives |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0839036B1 (xx) |
| JP (1) | JPH11509214A (xx) |
| KR (1) | KR19990028741A (xx) |
| CN (1) | CN1190345A (xx) |
| AT (1) | ATE183644T1 (xx) |
| AU (1) | AU690471B2 (xx) |
| CA (1) | CA2219501A1 (xx) |
| CZ (1) | CZ11698A3 (xx) |
| DE (1) | DE69603968T2 (xx) |
| DK (1) | DK0839036T3 (xx) |
| ES (1) | ES2138359T3 (xx) |
| GR (1) | GR3031096T3 (xx) |
| HU (1) | HUP9802736A3 (xx) |
| IL (1) | IL122302A (xx) |
| IT (1) | IT1275532B (xx) |
| NO (1) | NO980171L (xx) |
| SK (1) | SK4198A3 (xx) |
| WO (1) | WO1997003669A1 (xx) |
| ZA (1) | ZA965924B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852737B2 (en) | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
| ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| TW200613275A (en) * | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
| AR053023A1 (es) * | 2005-02-25 | 2007-04-18 | Recordati Ireland Ltd | Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen |
| EP2585051B2 (en) | 2010-06-23 | 2020-04-08 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
| PT2627173E (pt) | 2010-10-12 | 2015-07-24 | Medicines Co | Formulações de clevidipina em emulsão contendo agentes antimicrobianos |
| US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
| EP2654729B1 (en) | 2010-12-24 | 2016-05-04 | KRKA, d.d., Novo mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
-
1995
- 1995-07-14 IT ITMI951513A patent/IT1275532B/it active IP Right Grant
-
1996
- 1996-06-28 AT AT96924834T patent/ATE183644T1/de not_active IP Right Cessation
- 1996-06-28 JP JP9506222A patent/JPH11509214A/ja active Pending
- 1996-06-28 SK SK41-98A patent/SK4198A3/sk unknown
- 1996-06-28 DK DK96924834T patent/DK0839036T3/da active
- 1996-06-28 KR KR1019980700039A patent/KR19990028741A/ko not_active Application Discontinuation
- 1996-06-28 CZ CZ98116A patent/CZ11698A3/cs unknown
- 1996-06-28 IL IL12230296A patent/IL122302A/xx not_active IP Right Cessation
- 1996-06-28 HU HU9802736A patent/HUP9802736A3/hu unknown
- 1996-06-28 CN CN96195439A patent/CN1190345A/zh active Pending
- 1996-06-28 EP EP96924834A patent/EP0839036B1/en not_active Expired - Lifetime
- 1996-06-28 WO PCT/EP1996/002872 patent/WO1997003669A1/en not_active Application Discontinuation
- 1996-06-28 AU AU65164/96A patent/AU690471B2/en not_active Ceased
- 1996-06-28 ES ES96924834T patent/ES2138359T3/es not_active Expired - Lifetime
- 1996-06-28 CA CA002219501A patent/CA2219501A1/en not_active Abandoned
- 1996-06-28 DE DE69603968T patent/DE69603968T2/de not_active Expired - Fee Related
- 1996-07-12 ZA ZA965924A patent/ZA965924B/xx unknown
-
1998
- 1998-01-14 NO NO980171A patent/NO980171L/no not_active Application Discontinuation
-
1999
- 1999-08-26 GR GR990402179T patent/GR3031096T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL122302A0 (en) | 1998-04-05 |
| AU690471B2 (en) | 1998-04-23 |
| DE69603968D1 (de) | 1999-09-30 |
| ATE183644T1 (de) | 1999-09-15 |
| DK0839036T3 (da) | 2000-01-24 |
| ITMI951513A1 (it) | 1997-01-14 |
| HUP9802736A3 (en) | 2000-03-28 |
| SK4198A3 (en) | 1998-05-06 |
| KR19990028741A (ko) | 1999-04-15 |
| IT1275532B (it) | 1997-08-07 |
| EP0839036B1 (en) | 1999-08-25 |
| CZ11698A3 (cs) | 1998-06-17 |
| ZA965924B (en) | 1997-01-30 |
| WO1997003669A1 (en) | 1997-02-06 |
| GR3031096T3 (en) | 1999-12-31 |
| AU6516496A (en) | 1997-02-18 |
| ITMI951513A0 (it) | 1995-07-14 |
| JPH11509214A (ja) | 1999-08-17 |
| DE69603968T2 (de) | 2000-04-06 |
| NO980171D0 (no) | 1998-01-14 |
| NO980171L (no) | 1998-01-14 |
| CN1190345A (zh) | 1998-08-12 |
| ES2138359T3 (es) | 2000-01-01 |
| CA2219501A1 (en) | 1997-02-06 |
| HUP9802736A2 (hu) | 1999-03-29 |
| EP0839036A1 (en) | 1998-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9603530A3 (en) | Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments | |
| IL117728A0 (en) | Pharmaceutical compositions for transdermal administration | |
| IL117265A0 (en) | Benzazepine- benzoxazepine- and benzothiazepine-n-acetic acid derivatives their preparation and pharmaceutical compositions containing them | |
| HUT52089A (en) | Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| IL117193A0 (en) | Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them | |
| HU208256B (en) | Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood | |
| AU5157590A (en) | Pharmaceutical compositions for oral administration | |
| IL118483A (en) | Compounds for use in the preparation of medicaments for inhibiting vascular smooth muscle cell migration and pharmaceutical formulations containing them | |
| IL122302A (en) | Use of 1,4-dihydropyridine derivatives in the preparation of a medicament for the prevention and therapy of atherosclerotic degradation of arterial walls and pharmaceutical compositions containing such derivatives | |
| HUP9700005A3 (en) | 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent | |
| CA2100126A1 (en) | 5,10-Methylenetetrahydrofolic Acid-Cyclodextrin Inclusion Compounds | |
| IL112936A0 (en) | Quinolone - and - naphthyridone - carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| IL97501A0 (en) | 4-pyridone derivatives,their preparation and pharmaceutical compositions containing them | |
| HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| HUT58082A (en) | Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| UA35566C2 (uk) | Лікарський засіб для профілактики і лікування порушень ліпоїдного і холестеринового обміну речовин і спосіб профілактики і лікування цих порушень | |
| IL102032A0 (en) | 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| TW372962B (en) | Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient | |
| HUP9901247A3 (en) | Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency | |
| AU660296B2 (en) | Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same | |
| IT1237509B (it) | Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche | |
| IL108930A0 (en) | 2,3-Diamino-3- hydroxycarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| AU1448692A (en) | Gallic acid derivative, and pharmaceutical compositions containing it | |
| HUT60737A (en) | Process for producing new 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HU9302821D0 (en) | Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |